RIO DE JANEIRO, BRAZIL - São Paulo governor João Doria (PSDB) on Monday, June 14, said that clinical trials of the Butanvac vaccine, an immunizer against Covid-19 developed by the Butantan Institute, should begin by the end of June and that there are now 6 Latin American countries interested in its importation, should it be approved by the Brazilian Health Regulatory Agency (ANVISA) after trials are completed.
Last week, Brazil's health regulator authorized the Butanvac clinical trials to begin. At this stage, the immunizer - which has undergone laboratory tests - will be administered to humans.
According to Doria . . .